vialaudit

affiliate disclosure · we earn commission on some vendor links. audits, scores, and rankings are independent — vendors do not pay for placement. read more →

NEWS · 9 MIN·UPDATED 2026-11-12·BY ELI WHITMER

Kovera re-issued 46 certificates: 16 now carry vendor codes

Kovera re-issued 46 certificates from 3 August to 10 November 2026. 16 now carry a vendor code instead of the compound, including SS-31 renamed BQ-31.

QUICK ANSWER

Comparing Kovera Labs' public certificate records from 1 August to 10 November 2026, we found 46 certificates re-published with new dates between 3 August and 10 November. 24 changed their product name, and 16 of those are now listed under a vendor code or vendor product name, such as OBL-R3, SLYM2 and EDGE R3. 15 of the 16 are GLP-1-class or BPC-157/TB-500 certificates; the 16th, re-published on 10 November, is an SS-31 certificate now named BQ-31. On 8 of the 16 the LC-MS identification line itself changed from the compound to the code; on the other 8 the certificate body already printed the code in May 2026. Purity and net content did not change on the renamed certificates apart from three 0.01 mg differences, while two certificates that kept their names did change values.

Kovera Labs re-issued 46 certificates after our 1 August 2026 read of its public records. The new publication dates run from 3 August to 10 November 2026. 24 of the 46 changed their product name, and 16 of those are now listed under a vendor code or a vendor product name: OBL-R3 where the record said retatrutide, SLYM2 where it said tirzepatide, BQ-31 where it said SS-31.

Update, 12 November 2026. This piece first reported 45 re-issues, read on 3 November. On 10 November Kovera re-published a 46th, KVR-2026-963483, a 50 mg certificate for BioQuantum Sciences, lot QC 08 10. Its product name and LC-MS identification line changed from "SS-31" to "BQ-31". Purity (99.868%), net content (51.63 mg) and the certified date (8 May 2026) are unchanged. The expiration date moved from 10 May 2028 to 9 November 2028, the content specification from "50mg ± 10%" to "~50mg", and the record now adds a heavy metal line and separate endotoxin and heavy-metal reports. The vial photograph on the re-issued certificate still shows a label reading SS-31. It is the first code rename we have seen outside the GLP-1 and BPC-157/TB-500 set. The counts below now include it: 46 re-issues, 24 name changes, 16 codes, 8 identification lines changed.

Most of the change is in the labels. On 8 of the 16 the LC-MS identification line switched from the compound to the code between Kovera's 1 August record and the new certificate. On the other 8 the certificate body already printed the code in our first capture, on 26 May 2026; only the listing label caught up. Purity and net content are unchanged on all 24 renamed certificates apart from three 0.01 mg differences. Two certificates that kept their names did change values.

How we did it: we compared Kovera's public certificate records as read on 1 August, 3 November and 10 November 2026, and the certificate files Kovera now serves. We did not order, test or submit anything, and we did not contact Kovera or any of its clients.

What changed, certificate by certificate

"Client" is the business name printed on the public certificate. "Listed as" is the product name in Kovera's record on 1 August 2026. "ID line changed" means the LC-MS identification line moved from a compound name to the code between our two reads; "no" means it already printed the code on 26 May.

KVRClientListed as (1 Aug)Listed as nowRe-issuedID line changed
KVR-2026-5D3FC3Thryv MedicalTirzepatideSLYM21 Sepyes
KVR-2026-75F9DCThryv MedicalTirzepatideSLYM217 Sepyes
KVR-2026-89AEEBIon PeptideTirzepatideION-2T15 Octno
KVR-2026-30AD88BioEdge Research LabsTirzepatideEDGE T23 Augno
KVR-2026-753B14BioEdge Research LabsTirzepatideEDGE T23 Augno
KVR-2026-118A1BOnyx BioLabsRetatrutideOBL-R317 Sepyes
KVR-2026-AD0E47Onyx BioLabsRetatrutideOBL-R317 Sepyes
KVR-2026-39AAB2BioEdge Research LabsRetatrutideEDGE R33 Augyes
KVR-2026-77513BBioEdge Research LabsRetatrutideEDGE R33 Augno
KVR-2026-CBA2DAZenergySemaglutide/CagrilintideZEN-1/CAGRI3 Novno
KVR-2026-6CFDF1private clientSemaglutide/Cagrilintidea client code (not printed here)3 Novno
KVR-2026-0F9075ZenergyRetatrutide/CagrilintideZEN-3/CAGRI3 Novno
KVR-2026-BD148EGlacier AminosRetatrutide/CagrilintideGLA-3 RT/Cagrilintide3 Novyes
KVR-2026-09FFFABio Enhanced LabsBPC-157/TB-500Wolverine Blend3 Novno
KVR-2026-FDE772Alpine Aminos LLCBPC-157/TB-500AA-BPC-157/TB-5003 Novyes
KVR-2026-963483BioQuantum SciencesSS-31BQ-3110 Novyes

Thirteen of the 16 are GLP-1-class compounds: five tirzepatide, four retatrutide, two semaglutide/cagrilintide and two retatrutide/cagrilintide. Two are BPC-157/TB-500 blends, and one is SS-31. Most codes share a prefix with the client's own name — EDGE for BioEdge, OBL for Onyx BioLabs, ZEN for Zenergy, ION for Ion Peptide, GLA for Glacier Aminos, BQ for BioQuantum Sciences, AA for Alpine Aminos, whose lot numbers also start "AA-". SLYM2 has no visible link to Thryv Medical. One of the original identification lines, on KVR-2026-75F9DC, read "Tirzepetide", misspelt on the certificate.

On the six blends, the component lines on the new certificate files carry the new names too: ZEN-1 at 5.91 mg beside cagrilintide at 5.49 mg, "Pentadecapeptide" at 10.66 mg inside the Wolverine Blend. The measured amounts match Kovera's 1 August record exactly; only the names differ.

The remaining 8 renames are abbreviations or formatting, not codes — "N-Acetyl Selank Amidate" (selank) became "NA Selank Amidate", "CJC-1295 (No DAC)/Ipamorelin" became "CJC/Ipa" or "CJC + Ipa", and one name gained "10MG" at the end. Our CJC-1295 + ipamorelin lab record reads those blend certificates in full.

What the public page shows today

On 5 November 2026 we opened two of the renamed certificates on Kovera's public verify page in a browser, read-only.

KVRClient (as printed)Certified (as printed)Product (as printed)Also shown
KVR-2026-118A1BOnyx BioLabs05/13/2026OBL-R3batch RETA0526-20-1, labelled 20 mg
KVR-2026-5D3FC3Thryv Medical04/30/2026SLYM2four downloadable reports: COA, endotoxin, heavy metals, rapid sterility

Both pages loaded without an access code. The product field on 118A1B reads OBL-R3, but its batch number still starts with "RETA".

Same lot, two codes

Two lots in the renamed set were certified for two different clients, a pattern we covered in Reta One Labs and the shared COAs.

  • Lot 04202026TZ15 is certified for Thryv Medical (5D3FC3) and for BioEdge Research Labs (753B14), both at 99.864% purity and 13.90 mg. One certificate now reads SLYM2, the other EDGE T2.
  • Lot 04202026TZ10 is certified for Thryv Medical (75F9DC) and for BioEdge (30AD88), both at 99.949% and 11.36 mg. Again SLYM2 on one, EDGE T2 on the other.

Two certificates changed values

Two of the 22 re-issued certificates that kept their names did change the numbers a reader sees.

KVRClientProductPurityNet contentCertified dateRe-issued
KVR-2026-86672ERemedyX LabsGHK-Cu99.016% → 99.948%113.86 mg → 107.22 mg24 May → 11 Aug11 Aug
KVR-2026-007B56Coffee and PeppersMOTS-C99.978% → 99.947%11.58 mg → 11.52 mg5 Mar (unchanged)7 Oct

Neither is a rename. Both belong to the in-place revision pattern we first documented in Kovera revised 57 COAs in place: the same certificate number, the same file address, new figures.

Smaller changes ran across the whole set of 46:

  • Certified date. It moved on 35 of the 46. On all 26 BioEdge Research Labs certificates it now reads 3 August 2026, the re-issue day, in place of dates from 13 April to 27 July. On five of the ten 3 November certificates it moved forward by two days.
  • Expiration date. New on all 46, now about two years after the re-issue.
  • Content specification. The wording changed from "Xmg ± 10%" to "~Xmg" on every certificate except two that already read "~Xmg".
  • Heavy metals. The new records add a "Heavy Metal Screening" line.
  • Lot number. One changed: KVR-2026-A04CA6 (Instant Peptides) went from 2026-0259-E to 2026-0259-F.

For 42 of the 46, the new file sits at the same address as the old one; the other four moved to a different storage folder under the same file name.

Fourteen certificates the public lookup no longer serves

Separately, Kovera's public lookup did not return these 14 certificates when we read the records on 3 November 2026. Thirteen were first missing on 14 October; D32CA0 is new. "Last served" is our last successful read; a dash means we only ever saw it in our 26 May capture.

KVRClientProduct (as listed)Last served
KVR-2026-09EC68Phoenix Rising Peptides LLCBacteriostatic Water—
KVR-2026-290515Glacier AminosGHK-Cu1 Aug
KVR-2026-3012C3Lost Coast AminosBacteriostatic Water—
KVR-2026-43E23DRemedyX LabsGLP-T21 Aug
KVR-2026-5F342ACoffee and PeppersRetatrutide (body: GLP-3 RT)1 Aug
KVR-2026-65CAC0Glacier AminosTesamorelin1 Aug
KVR-2026-6D880DRemedyX LabsGLP-T21 Aug
KVR-2026-8D024ERemedyX LabsGLP-R3—
KVR-2026-8FA2E0Instant PeptidesMelanotan-21 Aug
KVR-2026-9C7886RemedyX LabsGLP-R31 Aug
KVR-2026-AEA105Glacier AminosAHK-Cu1 Aug
KVR-2026-BD6960private clienthGH w/dimer1 Aug
KVR-2026-D32CA0Ion PeptideCerebro Protein1 Aug
KVR-2026-FBD06AGlacier AminosSelank1 Aug

The record shows only that the lookup did not return them on 3 November. It does not say whether a certificate was withdrawn, replaced or is temporarily unavailable, and we do not guess. On 10 November 2026 the lookup still did not return any of the 14.

Dates

The re-issue dates, set beside regulatory events from the same months:

  • 3 Aug — 26 BioEdge Research Labs certificates re-issued, including four of the 16 code renames (30AD88, 753B14, 39AAB2, 77513B).
  • 7 Aug, 11 Aug — one Instant Peptides and one RemedyX Labs certificate.
  • 12 Aug — Eli Lilly files six retatrutide suits against sellers (our coverage).
  • 24 Aug — FDA warning letters to five research-peptide vendors.
  • 1 Sep — 5D3FC3 (Thryv Medical) re-issued as SLYM2.
  • 17 Sep — two Onyx BioLabs certificates as OBL-R3, one Thryv Medical as SLYM2.
  • 7 Oct — 007B56 and 00BD2C re-issued, names unchanged.
  • 8 Oct — Lilly files five more suits, 11 in total (our coverage).
  • 15 Oct — 89AEEB (Ion Peptide) re-issued as ION-2T.
  • 28 Oct — HHS files its peptide compounding enforcement discretion policy (our coverage).
  • 3 Nov — 10 certificates re-issued, six of them code renames.
  • 10 Nov — 963483 (BioQuantum Sciences) re-issued as BQ-31, listed as SS-31 before.

The largest batch, 3 August, predates both the Lilly suits and the FDA letters. Twelve of the 16 code renames fall after them. Dates set side by side are not evidence of cause, and we draw no conclusion about why any certificate was re-issued.

What this means if your certificate carries a code

If the certificate for a vial you hold names a code rather than a compound:

  1. The molecule may not appear anywhere on it. On a coded certificate the product field, the identification line and, on blends, the component lines can all carry the code. Sometimes the batch prefix is the only trace — "RETA" on OBL-R3. Codes like these are the subject of our piece on code-name catalogues, and of the GLP-3 RT naming explainer.
  2. Ask the seller in writing. Request the compound name and its CAS number for the product you bought. A certificate cannot answer that question if it does not print the name.
  3. Match the KVR code at the source. Compare the KVR code on the seller's page with the record on Kovera's own site, not with a PDF the seller hosts. Our guide to verifying a peptide COA walks through the six fields worth checking.
  4. Date your copy. A re-issued certificate carries a new expiration date and may carry a new certified date. Save the file with the date you retrieved it, so a later version can be compared against it.

What we read, and what we did not

  • Read. Kovera's public certificate records, as served on 1 August, 3 November and 10 November 2026; the certificate files Kovera served on 4 November, and the re-issued 963483 file served on 10 November; our first capture of the registry on 26 May 2026; and Kovera's public verify page for two certificates on 5 November.
  • Not held. We do not hold copies of the earlier certificate images for the re-issued files, and Kovera replaced them at the same address. "Before" in this piece means Kovera's own earlier data record, not the earlier image.
  • Not asked. We did not contact Kovera or any client named above.
  • Not checked. We did not look at any client's storefront for these codes, and make no claim about what any of them sells today.
  • Not tested. We placed no order and tested nothing.

We do not name the private client on KVR-2026-6CFDF1 or print its product code.

Frequently asked

What does OBL-R3, SLYM2 or EDGE R3 mean on a Kovera certificate?

Each is the product name now printed for a client's certificate. OBL-R3 appears on two Onyx BioLabs certificates that Kovera's record listed as retatrutide on 1 August 2026. SLYM2 appears on two Thryv Medical certificates listed as tirzepatide. EDGE R3 appears on two BioEdge Research Labs certificates listed as retatrutide. The record shows the client and the former listing name. It does not explain the code.

Did Kovera change any purity or content values on the renamed certificates?

Not materially. On all 24 renamed certificates the printed purity is the same as on 1 August 2026, and net content is the same apart from three 0.01 mg differences. Two certificates that kept their names did change values: a GHK-Cu certificate moved from 99.016% to 99.948% purity and from 113.86 mg to 107.22 mg, and a MOTS-C certificate moved from 99.978% to 99.947% and from 11.58 mg to 11.52 mg.

What is BQ-31 on a Kovera certificate?

BQ-31 is the product name now printed on KVR-2026-963483, a BioQuantum Sciences certificate that Kovera's record listed as SS-31 until it was re-published on 10 November 2026. The product field and the LC-MS identification line both changed from SS-31 to BQ-31. Purity (99.868%), net content (51.63 mg) and the certified date (8 May 2026) did not change. The vial photograph on the re-issued certificate still shows a label reading SS-31. The record does not explain the code.

Can I still verify a renamed Kovera certificate?

Yes. Look it up by its KVR code on Kovera's verify page. On 5 November 2026 we opened two renamed certificates in a browser, KVR-2026-118A1B and KVR-2026-5D3FC3. Both loaded without an access code and showed the new product names, OBL-R3 and SLYM2.

Why did Kovera re-issue these certificates?

We do not know. The records show dates, not reasons. The largest batch, 26 BioEdge Research Labs certificates, was re-issued on 3 August 2026, before the August Lilly lawsuits and FDA warning letters. We have not asked Kovera or any client, and we draw no conclusion about cause.

How do I check what compound a coded certificate covers?

Ask the seller for the compound name and CAS number in writing, then match the KVR code on the seller's page against the record on Kovera's own site. A coded certificate may not name the molecule anywhere except, sometimes, in the batch prefix.

More from the desk

ALL ARTICLES →
THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH